Xiao-Yu Zheng1, Qian-Quan Wan2, Chuan-Yi Zheng3
1Department of Intensive-Care Unit, Affiliated First Hospital, Jinan University, Guangzhou, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Human amniotic mesenchymal stem cells (hAM-MSCs) show promise for Alzheimer's disease (AD) treatment. Transplantation reduced amyloid-β plaques and improved memory in AD mice by modulating neuroinflammation and enhancing neurogenesis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: